 | • レポートコード：QY2203B01387 • 出版社/出版日：QYResearch / 2022年3月18日 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のアデノウイルス迅速検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアデノウイルス迅速検査の世界市場のxxx％を占める「ラテラルフローイミュノクロマトアッセイ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のアデノウイルス迅速検査の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのアデノウイルス迅速検査市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアデノウイルス迅速検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 アデノウイルス迅速検査のグローバル主要メーカーには、Biopanda Reagents、CTK Biotech、Creative Diagnostics、Intec PRODUCTS、Biomerieux、Accuquik、SA Scientific、F. Hoffmann-La Roche、Diasorin、Bio-Rad Laboratories、QIAGENなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アデノウイルス迅速検査市場は、種類と用途によって区分されます。世界のアデノウイルス迅速検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ラテラルフローイミュノクロマトアッセイ、イミュノゴールドアッセイ、PCR-酵素ハイブリダイゼーションアッセイ 【用途別セグメント】 病院、診断研究所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アデノウイルス迅速検査製品概要 - 種類別市場（ラテラルフローイミュノクロマトアッセイ、イミュノゴールドアッセイ、PCR-酵素ハイブリダイゼーションアッセイ） - 用途別市場（病院、診断研究所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアデノウイルス迅速検査販売量予測2017-2028 - 世界のアデノウイルス迅速検査売上予測2017-2028 - アデノウイルス迅速検査の地域別販売量 - アデノウイルス迅速検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アデノウイルス迅速検査販売量 - 主要メーカー別アデノウイルス迅速検査売上 - 主要メーカー別アデノウイルス迅速検査価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ラテラルフローイミュノクロマトアッセイ、イミュノゴールドアッセイ、PCR-酵素ハイブリダイゼーションアッセイ） - アデノウイルス迅速検査の種類別販売量 - アデノウイルス迅速検査の種類別売上 - アデノウイルス迅速検査の種類別価格 ・用途別市場規模（病院、診断研究所、その他） - アデノウイルス迅速検査の用途別販売量 - アデノウイルス迅速検査の用途別売上 - アデノウイルス迅速検査の用途別価格 ・北米市場 - 北米のアデノウイルス迅速検査市場規模（種類別、用途別） - 主要国別のアデノウイルス迅速検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアデノウイルス迅速検査市場規模（種類別、用途別） - 主要国別のアデノウイルス迅速検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアデノウイルス迅速検査市場規模（種類別、用途別） - 主要国別のアデノウイルス迅速検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアデノウイルス迅速検査市場規模（種類別、用途別） - 主要国別のアデノウイルス迅速検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアデノウイルス迅速検査市場規模（種類別、用途別） - 主要国別のアデノウイルス迅速検査市場規模（トルコ、サウジアラビア） ・企業情報 Biopanda Reagents、CTK Biotech、Creative Diagnostics、Intec PRODUCTS、Biomerieux、Accuquik、SA Scientific、F. Hoffmann-La Roche、Diasorin、Bio-Rad Laboratories、QIAGEN ・産業チェーン及び販売チャネル分析 - アデノウイルス迅速検査の産業チェーン分析 - アデノウイルス迅速検査の原材料 - アデノウイルス迅速検査の生産プロセス - アデノウイルス迅速検査の販売及びマーケティング - アデノウイルス迅速検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アデノウイルス迅速検査の産業動向 - アデノウイルス迅速検査のマーケットドライバー - アデノウイルス迅速検査の課題 - アデノウイルス迅速検査の阻害要因 ・主な調査結果 |
People with compromised immunity are at increased risk of serious illness caused by adenovirus infection. Adenovirus is a very common infection and according to WHO it is estimated to be responsible for 2% to 5% of all respiratory diseases. Several laboratory tests are available for the diagnosis of adenovirus eye infections. Adenovirus diagnostic tests detect the presence of double-stranded DNA virus found in adenoid tissue. Rapid diagnosis of human adenovirus (HAdV) infection has been achieved by PCR, will aid in treatment and diagnosis of adenovirus infections.
Market Analysis and Insights: Global Rapid Adenovirus Testing Market
Due to the COVID-19 pandemic, the global Rapid Adenovirus Testing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Lateral Flow Immunochromatographic Assay accounting for % of the Rapid Adenovirus Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Rapid Adenovirus Testing market size is valued at US$ million in 2021, while the US and Europe Rapid Adenovirus Testing are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Rapid Adenovirus Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Rapid Adenovirus Testing include Biopanda Reagents, CTK Biotech, Creative Diagnostics, Intec PRODUCTS, Biomerieux, Accuquik, SA Scientific, F. Hoffmann-La Roche and Diasorin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Rapid Adenovirus Testing Scope and Segment
Rapid Adenovirus Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rapid Adenovirus Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Lateral Flow Immunochromatographic Assay
Immunogold Assay
PCR-Enzyme Hybridization Assay
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Company
Biopanda Reagents
CTK Biotech
Creative Diagnostics
Intec PRODUCTS
Biomerieux
Accuquik
SA Scientific
F. Hoffmann-La Roche
Diasorin
Bio-Rad Laboratories
QIAGEN
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Rapid Adenovirus Testing Product Introduction
1.2 Market by Type
1.2.1 Global Rapid Adenovirus Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lateral Flow Immunochromatographic Assay
1.2.3 Immunogold Assay
1.2.4 PCR-Enzyme Hybridization Assay
1.3 Market by Application
1.3.1 Global Rapid Adenovirus Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rapid Adenovirus Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Rapid Adenovirus Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Rapid Adenovirus Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rapid Adenovirus Testing Sales by Region
2.4.1 Global Rapid Adenovirus Testing Sales by Region (2017-2022)
2.4.2 Global Sales Rapid Adenovirus Testing by Region (2023-2028)
2.5 Global Rapid Adenovirus Testing Revenue by Region
2.5.1 Global Rapid Adenovirus Testing Revenue by Region (2017-2022)
2.5.2 Global Rapid Adenovirus Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rapid Adenovirus Testing Sales by Manufacturers
3.1.1 Global Top Rapid Adenovirus Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Rapid Adenovirus Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rapid Adenovirus Testing in 2021
3.2 Global Rapid Adenovirus Testing Revenue by Manufacturers
3.2.1 Global Rapid Adenovirus Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Rapid Adenovirus Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rapid Adenovirus Testing Revenue in 2021
3.3 Global Rapid Adenovirus Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rapid Adenovirus Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rapid Adenovirus Testing Sales by Type
4.1.1 Global Rapid Adenovirus Testing Historical Sales by Type (2017-2022)
4.1.2 Global Rapid Adenovirus Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
4.2 Global Rapid Adenovirus Testing Revenue by Type
4.2.1 Global Rapid Adenovirus Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Rapid Adenovirus Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
4.3 Global Rapid Adenovirus Testing Price by Type
4.3.1 Global Rapid Adenovirus Testing Price by Type (2017-2022)
4.3.2 Global Rapid Adenovirus Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rapid Adenovirus Testing Sales by Application
5.1.1 Global Rapid Adenovirus Testing Historical Sales by Application (2017-2022)
5.1.2 Global Rapid Adenovirus Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
5.2 Global Rapid Adenovirus Testing Revenue by Application
5.2.1 Global Rapid Adenovirus Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Rapid Adenovirus Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
5.3 Global Rapid Adenovirus Testing Price by Application
5.3.1 Global Rapid Adenovirus Testing Price by Application (2017-2022)
5.3.2 Global Rapid Adenovirus Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rapid Adenovirus Testing Market Size by Type
6.1.1 North America Rapid Adenovirus Testing Sales by Type (2017-2028)
6.1.2 North America Rapid Adenovirus Testing Revenue by Type (2017-2028)
6.2 North America Rapid Adenovirus Testing Market Size by Application
6.2.1 North America Rapid Adenovirus Testing Sales by Application (2017-2028)
6.2.2 North America Rapid Adenovirus Testing Revenue by Application (2017-2028)
6.3 North America Rapid Adenovirus Testing Market Size by Country
6.3.1 North America Rapid Adenovirus Testing Sales by Country (2017-2028)
6.3.2 North America Rapid Adenovirus Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Rapid Adenovirus Testing Market Size by Type
7.1.1 Europe Rapid Adenovirus Testing Sales by Type (2017-2028)
7.1.2 Europe Rapid Adenovirus Testing Revenue by Type (2017-2028)
7.2 Europe Rapid Adenovirus Testing Market Size by Application
7.2.1 Europe Rapid Adenovirus Testing Sales by Application (2017-2028)
7.2.2 Europe Rapid Adenovirus Testing Revenue by Application (2017-2028)
7.3 Europe Rapid Adenovirus Testing Market Size by Country
7.3.1 Europe Rapid Adenovirus Testing Sales by Country (2017-2028)
7.3.2 Europe Rapid Adenovirus Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rapid Adenovirus Testing Market Size by Type
8.1.1 Asia Pacific Rapid Adenovirus Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Rapid Adenovirus Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Rapid Adenovirus Testing Market Size by Application
8.2.1 Asia Pacific Rapid Adenovirus Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Rapid Adenovirus Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Rapid Adenovirus Testing Market Size by Region
8.3.1 Asia Pacific Rapid Adenovirus Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Rapid Adenovirus Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rapid Adenovirus Testing Market Size by Type
9.1.1 Latin America Rapid Adenovirus Testing Sales by Type (2017-2028)
9.1.2 Latin America Rapid Adenovirus Testing Revenue by Type (2017-2028)
9.2 Latin America Rapid Adenovirus Testing Market Size by Application
9.2.1 Latin America Rapid Adenovirus Testing Sales by Application (2017-2028)
9.2.2 Latin America Rapid Adenovirus Testing Revenue by Application (2017-2028)
9.3 Latin America Rapid Adenovirus Testing Market Size by Country
9.3.1 Latin America Rapid Adenovirus Testing Sales by Country (2017-2028)
9.3.2 Latin America Rapid Adenovirus Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Rapid Adenovirus Testing Market Size by Type
10.1.1 Middle East and Africa Rapid Adenovirus Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rapid Adenovirus Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Rapid Adenovirus Testing Market Size by Application
10.2.1 Middle East and Africa Rapid Adenovirus Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rapid Adenovirus Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Rapid Adenovirus Testing Market Size by Country
10.3.1 Middle East and Africa Rapid Adenovirus Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Biopanda Reagents
11.1.1 Biopanda Reagents Corporation Information
11.1.2 Biopanda Reagents Overview
11.1.3 Biopanda Reagents Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Biopanda Reagents Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biopanda Reagents Recent Developments
11.2 CTK Biotech
11.2.1 CTK Biotech Corporation Information
11.2.2 CTK Biotech Overview
11.2.3 CTK Biotech Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CTK Biotech Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CTK Biotech Recent Developments
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics Corporation Information
11.3.2 Creative Diagnostics Overview
11.3.3 Creative Diagnostics Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Creative Diagnostics Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Creative Diagnostics Recent Developments
11.4 Intec PRODUCTS
11.4.1 Intec PRODUCTS Corporation Information
11.4.2 Intec PRODUCTS Overview
11.4.3 Intec PRODUCTS Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Intec PRODUCTS Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Intec PRODUCTS Recent Developments
11.5 Biomerieux
11.5.1 Biomerieux Corporation Information
11.5.2 Biomerieux Overview
11.5.3 Biomerieux Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biomerieux Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biomerieux Recent Developments
11.6 Accuquik
11.6.1 Accuquik Corporation Information
11.6.2 Accuquik Overview
11.6.3 Accuquik Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Accuquik Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Accuquik Recent Developments
11.7 SA Scientific
11.7.1 SA Scientific Corporation Information
11.7.2 SA Scientific Overview
11.7.3 SA Scientific Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 SA Scientific Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SA Scientific Recent Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Corporation Information
11.8.2 F. Hoffmann-La Roche Overview
11.8.3 F. Hoffmann-La Roche Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 F. Hoffmann-La Roche Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 F. Hoffmann-La Roche Recent Developments
11.9 Diasorin
11.9.1 Diasorin Corporation Information
11.9.2 Diasorin Overview
11.9.3 Diasorin Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Diasorin Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Diasorin Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Corporation Information
11.10.2 Bio-Rad Laboratories Overview
11.10.3 Bio-Rad Laboratories Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bio-Rad Laboratories Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 QIAGEN
11.11.1 QIAGEN Corporation Information
11.11.2 QIAGEN Overview
11.11.3 QIAGEN Rapid Adenovirus Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 QIAGEN Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 QIAGEN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rapid Adenovirus Testing Industry Chain Analysis
12.2 Rapid Adenovirus Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rapid Adenovirus Testing Production Mode & Process
12.4 Rapid Adenovirus Testing Sales and Marketing
12.4.1 Rapid Adenovirus Testing Sales Channels
12.4.2 Rapid Adenovirus Testing Distributors
12.5 Rapid Adenovirus Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rapid Adenovirus Testing Industry Trends
13.2 Rapid Adenovirus Testing Market Drivers
13.3 Rapid Adenovirus Testing Market Challenges
13.4 Rapid Adenovirus Testing Market Restraints
14 Key Findings in The Global Rapid Adenovirus Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Rapid Adenovirus Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lateral Flow Immunochromatographic Assay
Table 3. Major Manufacturers of Immunogold Assay
Table 4. Major Manufacturers of PCR-Enzyme Hybridization Assay
Table 5. Global Rapid Adenovirus Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Rapid Adenovirus Testing Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Rapid Adenovirus Testing Sales by Region (2017-2022) & (K Units)
Table 8. Global Rapid Adenovirus Testing Sales Market Share by Region (2017-2022)
Table 9. Global Rapid Adenovirus Testing Sales by Region (2023-2028) & (K Units)
Table 10. Global Rapid Adenovirus Testing Sales Market Share by Region (2023-2028)
Table 11. Global Rapid Adenovirus Testing Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Rapid Adenovirus Testing Revenue Market Share by Region (2017-2022)
Table 13. Global Rapid Adenovirus Testing Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Rapid Adenovirus Testing Revenue Market Share by Region (2023-2028)
Table 15. Global Rapid Adenovirus Testing Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Rapid Adenovirus Testing Sales Share by Manufacturers (2017-2022)
Table 17. Global Rapid Adenovirus Testing Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Rapid Adenovirus Testing Revenue Share by Manufacturers (2017-2022)
Table 19. Rapid Adenovirus Testing Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Rapid Adenovirus Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Rapid Adenovirus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Adenovirus Testing as of 2021)
Table 22. Rapid Adenovirus Testing Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Rapid Adenovirus Testing Product Offered
Table 24. Date of Manufacturers Enter into Rapid Adenovirus Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 27. Global Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 28. Global Rapid Adenovirus Testing Sales Share by Type (2017-2022)
Table 29. Global Rapid Adenovirus Testing Sales Share by Type (2023-2028)
Table 30. Global Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Rapid Adenovirus Testing Revenue Share by Type (2017-2022)
Table 33. Global Rapid Adenovirus Testing Revenue Share by Type (2023-2028)
Table 34. Rapid Adenovirus Testing Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Rapid Adenovirus Testing Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 37. Global Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 38. Global Rapid Adenovirus Testing Sales Share by Application (2017-2022)
Table 39. Global Rapid Adenovirus Testing Sales Share by Application (2023-2028)
Table 40. Global Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Rapid Adenovirus Testing Revenue Share by Application (2017-2022)
Table 43. Global Rapid Adenovirus Testing Revenue Share by Application (2023-2028)
Table 44. Rapid Adenovirus Testing Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Rapid Adenovirus Testing Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 47. North America Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 48. North America Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 51. North America Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 52. North America Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Rapid Adenovirus Testing Sales by Country (2017-2022) & (K Units)
Table 55. North America Rapid Adenovirus Testing Sales by Country (2023-2028) & (K Units)
Table 56. North America Rapid Adenovirus Testing Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Rapid Adenovirus Testing Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 59. Europe Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 60. Europe Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 63. Europe Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 64. Europe Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Rapid Adenovirus Testing Sales by Country (2017-2022) & (K Units)
Table 67. Europe Rapid Adenovirus Testing Sales by Country (2023-2028) & (K Units)
Table 68. Europe Rapid Adenovirus Testing Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Rapid Adenovirus Testing Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Rapid Adenovirus Testing Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Rapid Adenovirus Testing Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Rapid Adenovirus Testing Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Rapid Adenovirus Testing Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Rapid Adenovirus Testing Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Rapid Adenovirus Testing Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Rapid Adenovirus Testing Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Rapid Adenovirus Testing Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Rapid Adenovirus Testing Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Rapid Adenovirus Testing Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Rapid Adenovirus Testing Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Rapid Adenovirus Testing Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Rapid Adenovirus Testing Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Rapid Adenovirus Testing Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Rapid Adenovirus Testing Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Rapid Adenovirus Testing Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Rapid Adenovirus Testing Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Rapid Adenovirus Testing Revenue by Country (2023-2028) & (US$ Million)
Table 106. Biopanda Reagents Corporation Information
Table 107. Biopanda Reagents Description and Major Businesses
Table 108. Biopanda Reagents Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Biopanda Reagents Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Biopanda Reagents Recent Developments
Table 111. CTK Biotech Corporation Information
Table 112. CTK Biotech Description and Major Businesses
Table 113. CTK Biotech Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. CTK Biotech Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. CTK Biotech Recent Developments
Table 116. Creative Diagnostics Corporation Information
Table 117. Creative Diagnostics Description and Major Businesses
Table 118. Creative Diagnostics Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Creative Diagnostics Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Creative Diagnostics Recent Developments
Table 121. Intec PRODUCTS Corporation Information
Table 122. Intec PRODUCTS Description and Major Businesses
Table 123. Intec PRODUCTS Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Intec PRODUCTS Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Intec PRODUCTS Recent Developments
Table 126. Biomerieux Corporation Information
Table 127. Biomerieux Description and Major Businesses
Table 128. Biomerieux Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Biomerieux Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Biomerieux Recent Developments
Table 131. Accuquik Corporation Information
Table 132. Accuquik Description and Major Businesses
Table 133. Accuquik Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Accuquik Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Accuquik Recent Developments
Table 136. SA Scientific Corporation Information
Table 137. SA Scientific Description and Major Businesses
Table 138. SA Scientific Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. SA Scientific Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. SA Scientific Recent Developments
Table 141. F. Hoffmann-La Roche Corporation Information
Table 142. F. Hoffmann-La Roche Description and Major Businesses
Table 143. F. Hoffmann-La Roche Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. F. Hoffmann-La Roche Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. F. Hoffmann-La Roche Recent Developments
Table 146. Diasorin Corporation Information
Table 147. Diasorin Description and Major Businesses
Table 148. Diasorin Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Diasorin Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Diasorin Recent Developments
Table 151. Bio-Rad Laboratories Corporation Information
Table 152. Bio-Rad Laboratories Description and Major Businesses
Table 153. Bio-Rad Laboratories Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Bio-Rad Laboratories Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Bio-Rad Laboratories Recent Developments
Table 156. QIAGEN Corporation Information
Table 157. QIAGEN Description and Major Businesses
Table 158. QIAGEN Rapid Adenovirus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. QIAGEN Rapid Adenovirus Testing Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. QIAGEN Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Rapid Adenovirus Testing Distributors List
Table 164. Rapid Adenovirus Testing Customers List
Table 165. Rapid Adenovirus Testing Market Trends
Table 166. Rapid Adenovirus Testing Market Drivers
Table 167. Rapid Adenovirus Testing Market Challenges
Table 168. Rapid Adenovirus Testing Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Rapid Adenovirus Testing Product Picture
Figure 3. Global Rapid Adenovirus Testing Market Share by Type in 2021 & 2028
Figure 3. Lateral Flow Immunochromatographic Assay Product Picture
Figure 4. Immunogold Assay Product Picture
Figure 5. PCR-Enzyme Hybridization Assay Product Picture
Figure 6. Global Rapid Adenovirus Testing Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Diagnostic Laboratories
Figure 9. Others
Figure 10. Rapid Adenovirus Testing Report Years Considered
Figure 11. Global Rapid Adenovirus Testing Sales 2017-2028 (K Units)
Figure 12. Global Rapid Adenovirus Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Rapid Adenovirus Testing Revenue 2017-2028 (US$ Million)
Figure 14. Global Rapid Adenovirus Testing Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Rapid Adenovirus Testing Sales Market Share by Region (2017-2022)
Figure 16. Global Rapid Adenovirus Testing Sales Market Share by Region (2023-2028)
Figure 17. North America Rapid Adenovirus Testing Sales YoY (2017-2028) & (K Units)
Figure 18. North America Rapid Adenovirus Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Rapid Adenovirus Testing Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Rapid Adenovirus Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Rapid Adenovirus Testing Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Rapid Adenovirus Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Rapid Adenovirus Testing Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Rapid Adenovirus Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Rapid Adenovirus Testing Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Rapid Adenovirus Testing Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Rapid Adenovirus Testing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Rapid Adenovirus Testing in the World: Market Share by Rapid Adenovirus Testing Revenue in 2021
Figure 29. Global Rapid Adenovirus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 31. Global Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 32. Global Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 33. Global Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 34. North America Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 35. North America Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 36. North America Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 37. North America Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 38. North America Rapid Adenovirus Testing Sales Share by Country (2017-2028)
Figure 39. North America Rapid Adenovirus Testing Revenue Share by Country (2017-2028)
Figure 40. United States Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 43. Europe Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 44. Europe Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 45. Europe Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 46. Europe Rapid Adenovirus Testing Sales Share by Country (2017-2028)
Figure 47. Europe Rapid Adenovirus Testing Revenue Share by Country (2017-2028)
Figure 48. Germany Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 49. France Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Rapid Adenovirus Testing Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Rapid Adenovirus Testing Revenue Share by Region (2017-2028)
Figure 59. China Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 62. India Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 69. Latin America Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 71. Latin America Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Rapid Adenovirus Testing Sales Share by Country (2017-2028)
Figure 73. Latin America Rapid Adenovirus Testing Revenue Share by Country (2017-2028)
Figure 74. Mexico Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Rapid Adenovirus Testing Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Rapid Adenovirus Testing Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Rapid Adenovirus Testing Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Rapid Adenovirus Testing Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Rapid Adenovirus Testing Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Rapid Adenovirus Testing Revenue Share by Country (2017-2028)
Figure 84. Turkey Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Rapid Adenovirus Testing Revenue (2017-2028) & (US$ Million)
Figure 87. Rapid Adenovirus Testing Value Chain
Figure 88. Rapid Adenovirus Testing Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed